Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

    August 2025 in “ Drug Design Development and Therapy ”
    Shuting Chen, Ling Li, Weifeng Ding … N. Zhou
    Studysummary This review article examines current drugs for androgenetic alopecia, focusing on their mechanisms and clinical efficacy, noting that while finasteride and minoxidil are commonly approved treatments, new drugs targeting different pathogenic pathways have emerged, offering a broader understanding and reference for AGA treatment options.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dovepress.com →
    Discuss this study in the Community →

    Research cited in this study 98

    1. Botulinum Toxin in the Treatment of Hair and Scalp Disorders: Current Evidence and Clinical Applications Toxins · 2025
    2. Does the Transient Hair Shedding Phase Exist After Minoxidil Treatment and Predict Treatment Efficacy? A Retrospective Study in Androgenetic Alopecia Patients Journal of Dermatological Treatment · 2025
    3. Efficacy and Safety of Topical Finasteride Spray Solution in the Treatment of Chinese Men with Androgenetic Alopecia: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Chinese Medical Journal · 2025
    4. Immune and Non-Immune Interactions in the Pathogenesis of Androgenetic Alopecia Clinical Reviews in Allergy & Immunology · 2025
    5. Assessing the Safety of Topical Minoxidil Through Disproportionality Analysis of FAERS Reports Expert Opinion on Drug Safety · 2025
    6. Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence Healthcare · 2025
    7. Boosting Skin Microcirculation for Androgenetic Alopecia: Does It Work? Journal of Investigative Dermatology · 2025
    8. Progress on Mitochondria and Hair Follicle Development in Androgenetic Alopecia: Relationships and Therapeutic Perspectives Stem Cell Research & Therapy · 2025
    9. Assessing Causality Between Androgenetic Alopecia With Depression: A Bidirectional Mendelian Randomization Study Clinical Cosmetic and Investigational Dermatology · 2025
    10. Caffeine as an Active Molecule in Cosmetic Products for Hair Loss: Its Mechanisms of Action in the Context of Hair Physiology and Pathology Molecules · 2025
    11. Differential Expression of CXCL12 in Human and Mouse Hair: Androgens Induce CXCL12 in Human Dermal Papilla and Dermal Sheath Cup International Journal of Molecular Sciences · 2024
    12. A Randomized, Placebo-Controlled Clinical Study Evaluating a Dietary Supplement for Hair Growth PubMed · 2024
    13. Micronutrients And Androgenetic Alopecia: A Systematic Review Molecular Nutrition & Food Research · 2024
    14. Efficacy and Safety of Oral Minoxidil Versus Topical Solution in Androgenetic Alopecia: A Meta-Analysis of Randomized Clinical Trials International Journal of Dermatology · 2024
    15. Efficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in the Treatment of Male Pattern Androgenic Alopecia Journal of Drugs in Dermatology · 2024
    16. Clinical And Preclinical Approach In AGA Treatment: A Review Of Current And New Therapies In The Regenerative Field Stem Cell Research & Therapy · 2024
    17. Physical Treatments and Therapies for Androgenetic Alopecia Journal of Clinical Medicine · 2024
    18. Small Molecule Agents Against Alopecia: Potential Targets And Related Pathways European Journal of Medicinal Chemistry · 2024
    19. A Bibliometric Analysis of Alternative Drug Therapy Options in the Treatment of Androgenetic Alopecia Journal of cosmetic dermatology · 2024
    20. Hair Thickness Growth Effect of Adenosine Complex in Male and Female Patterned Hair Loss via Inhibition of Androgen Receptor Signaling International journal of molecular sciences · 2024
    21. Topical Minoxidil Rejuvenates Hair Follicles in Men with Androgenetic Alopecia In Vivo Acta dermato-venereologica · 2024
    22. Split-Scalp Pilot Study to Evaluate Effectiveness of Minoxidil 0.5% MMP® Versus Topical Minoxidil 5% in the Treatment of Female Pattern Hair Loss Archives of dermatological research · 2024
    23. Efficacy and Safety of Spironolactone Versus Bicalutamide in Female Pattern Hair Loss: A Retrospective Comparative Study Australasian journal of dermatology · 2024
    24. Management of Androgenic Alopecia: A Systematic Review of the Literature Journal of cosmetic and laser therapy · 2024
    25. Non-Cicatricial Alopecia and Its Association with Anthropometric Measurements and Nutritional Laboratory Markers Life · 2024
    26. Clinical Studies Using Topical Melatonin International journal of molecular sciences · 2024
    27. Patient-Reported Outcomes of Topical Finasteride/Minoxidil Treatment for Male Androgenetic Alopecia: A Retrospective Study Using Telemedical Data Journal of cosmetic dermatology · 2024
    28. Comparative Efficacy and Safety of JAK Inhibitors in the Treatment of Moderate-to-Severe Alopecia Areata: A Systematic Review and Network Meta-Analysis Frontiers in pharmacology · 2024
    29. Sexual Dysfunction With 5-Alpha-Reductase Inhibitor Therapy for Androgenetic Alopecia: A Global Propensity Score Matched Retrospective Cohort Study Journal of the American Academy of Dermatology · 2024
    30. Combating Dread Shed: The Impact of Overlapping Topical and Oral Minoxidil on Temporary Hair Shedding During Oral Minoxidil Initiation JAAD International · 2024
    31. A Review of Isotretinoin in the Treatment of Frontal Fibrosing Alopecia Journal of cosmetic dermatology · 2024
    32. The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia International Journal of Molecular Sciences · 2024
    33. CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata International Journal of Molecular Sciences · 2024
    34. Serum 25 Hydroxyvitamin D in Non-Scarring Alopecia: A Systematic Review and Meta-Analysis Journal of Cosmetic Dermatology · 2023
    35. Evaluating 5 Alpha Reductase Inhibitors for the Treatment of Male Androgenic Alopecia Expert Opinion on Pharmacotherapy · 2023
    36. Botulinum Toxin A for Hair Loss Treatment: A Systematic Review of Efficacy, Safety, and Future Directions JPRAS Open · 2023
    37. Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women Cureus · 2023
    38. Efficacy of Topical Minoxidil and Oral Spironolactone Versus Minoxidil and Finasteride in Androgenic Alopecia Journal of Cosmetic Dermatology · 2023
    39. Therapeutic Effects of Topical Cetirizine in the Treatment of Female Pattern Hair Loss: A Randomized Controlled Noninferiority Trial Expert Review of Clinical Pharmacology · 2023
    40. New Target for Minoxidil in the Treatment of Androgenetic Alopecia Drug Design Development and Therapy · 2023
    41. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review Dermatology and Therapy · 2023
    42. Evaluation of the Therapeutic Effects of AGA Drugs by Measuring Finasteride, Dutasteride, and Dihydrotestosterone in Hair Clinica Chimica Acta · 2023
    43. Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs Clinical, Cosmetic and Investigational Dermatology · 2023
    44. Female Pattern Hair Loss: Therapeutic Update Anais Brasileiros De Dermatologia · 2023
    45. A Systematic Review of Clinical Trials Using Single or Combination Therapy of Oral or Topical Finasteride for Women in Reproductive Age and Postmenopausal Women with Hormonal and Nonhormonal Androgenetic Alopecia Advances in Clinical and Experimental Medicine · 2023
    46. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review Clinical, Cosmetic and Investigational Dermatology · 2023
    47. CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2 Cells · 2023
    48. The Physiological and Pharmacological Roles of Prostaglandins in Hair Growth The Korean Journal of Physiology and Pharmacology · 2022
    49. Characteristics of Patients with Hair Loss After Isotretinoin Treatment International Journal of Trichology · 2022
    50. Anti-Hair Loss Effect of Adenosine Is Exerted by cAMP Mediated Wnt/β-Catenin Pathway Stimulation via Modulation of GSK3β Activity in Cultured Human Dermal Papilla Cells Molecules · 2022
    51. Topical Finasteride for Male and Female Pattern Hair Loss: Is It a Safe and Effective Alternative? Journal of Cosmetic Dermatology · 2022
    52. Preparation of Topical Bimatoprost with Enhanced Skin Infiltration and In Vivo Hair Regrowth Efficacy in Androgenic Alopecia Drug Delivery · 2022
    53. Androgen Receptor-Mediated Paracrine Signaling Induces Regression of Blood Vessels in the Dermal Papilla in Androgenetic Alopecia Journal of Investigative Dermatology · 2022
    54. Treatment with Oral Vitamin D Alone, Topical Minoxidil, or Combination of Both in Patients with Female Pattern Hair Loss: A Comparative Clinical and Dermoscopic Study Journal of Cosmetic Dermatology · 2022
    55. Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review Cureus · 2021
    56. Efficacy Comparison of Monotherapies and Combination Therapies for Androgenetic Alopecia: A Bayesian Network Meta-Analysis Dermatologic Therapy · 2021
    57. Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics Journal of Cosmetic Dermatology · 2021
    58. Are Janus Kinase (JAK) Inhibitors Beneficial in the Treatment of Androgenic Alopecia? International Journal of Dermatology · 2021
    59. Association Between Serum Zinc Levels and Androgenetic Alopecia: A Systematic Review and Meta-Analysis Journal of Cosmetic Dermatology · 2021
    60. Transcriptome Analysis Reveals an Inhibitory Effect of Dihydrotestosterone-Treated 2D- and 3D-Cultured Dermal Papilla Cells on Hair Follicle Growth Frontiers in Cell and Developmental Biology · 2021
    61. Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review Skin appendage disorders · 2021
    62. Utilities of Botulinum Toxins in Dermatology and Cosmetology Clinical Cosmetic and Investigational Dermatology · 2021
    63. Efficacy and Safety Profile of Oral Spironolactone Use for Androgenic Alopecia: A Systematic Review PubMed · 2021
    64. Minoxidil: A Comprehensive Review Journal of Dermatological Treatment · 2021
    65. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-Blind Controlled Study Journal of Pharmacy and Pharmaceutical Sciences · 2021
    66. Evaluation of Biophysical Skin Parameters and Hair Changes in Patients with Acne Vulgaris Treated with Isotretinoin, and the Effect of Biotin Use on These Parameters International Journal of Dermatology · 2021
    67. Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review Toxins · 2021
    68. Association of Fibrosis in the Bulge Portion with Hair Follicle Miniaturization in Androgenetic Alopecia Journal of The American Academy of Dermatology · 2021
    69. The Role of Prostaglandins in Androgenetic Alopecia International Journal of Dermatology · 2021
    70. Nonscarring Scalp Alopecia: Which Laboratory Analysis Should We Perform on Whom? Turkish Journal of Medical Sciences · 2021
    71. A Novel Topical Combination of Minoxidil and Spironolactone for Androgenetic Alopecia: Clinical, Histopathological, and Physicochemical Study Dermatologic Therapy · 2020
    72. Consensus on the Use of Oral Isotretinoin in Dermatology - Brazilian Society of Dermatology Anais Brasileiros de Dermatologia · 2020
    73. At The Crossroads Of Two Alopecias: Androgenetic Alopecia Pattern Of Hair Regrowth In Patients With Alopecia Areata Treated With Oral Janus Kinase Inhibitors JAAD case reports · 2020
    74. The Effect of Intradermal Botulinum Toxin on Androgenetic Alopecia and Its Possible Mechanism Journal of The American Academy of Dermatology · 2020
    75. Bicalutamide: A Potential New Oral Antiandrogenic Drug for Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2020
    76. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-Analysis Aesthetic Plastic Surgery · 2020
    77. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution PubMed · 2020
    78. Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia BioMed Research International · 2020
    79. Caffeine and Its Pharmacological Benefits in the Management of Androgenetic Alopecia: A Review Skin Pharmacology and Physiology · 2020
    80. Topical Ketoconazole for the Treatment of Androgenetic Alopecia: A Systematic Review Dermatologic Therapy · 2019
    81. Mechanism of Androgenic Alopecia: Addressing Speculations Through Empirical Evidence Dermatologic Therapy · 2019
    82. Vascular Endothelial Growth Factor Protects CD200-Rich and CD34-Positive Hair Follicle Stem Cells Against Androgen-Induced Apoptosis Through the Phosphoinositide 3-Kinase/Akt Pathway in Patients With Androgenic Alopecia Dermatologic Surgery · 2019
    83. Microbiome in the Hair Follicle of Androgenetic Alopecia Patients PLOS ONE · 2019
    84. A Small Dose of Botulinum Toxin A Is Effective for Treating Androgenetic Alopecia in Chinese Patients Dermatologic Therapy · 2018
    85. Guidelines for the Diagnosis and Treatment of Male-Pattern and Female-Pattern Hair Loss, 2017 Version Journal of Dermatology · 2018
    86. A Hypothetical Pathogenesis Model for Androgenic Alopecia: Clarifying the Dihydrotestosterone Paradox and Rate-Limiting Recovery Factors Medical Hypotheses · 2017
    87. Efficacy of Topical Tofacitinib in Promoting Hair Growth in Non-Scarring Alopecia: Possible Mechanism via VEGF Induction Archives of Dermatological Research · 2017
    88. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% Versus Minoxidil 5% Solution in Male Androgenetic Alopecia Skin Pharmacology and Physiology · 2017
    89. Topical Adenosine Increases Thick Hair Ratio in Japanese Men with Androgenetic Alopecia International Journal of Cosmetic Science · 2015
    90. Destruction of the Arrector Pili Muscle and Fat Infiltration in Androgenic Alopecia British Journal of Dermatology · 2014
    91. Female Pattern Alopecia: Current Perspectives International Journal of Women's Health · 2013
    92. Comparison of the Efficacy of Topical Minoxidil 5% and Adenosine 0.75% Solutions on Male Androgenetic Alopecia and Measuring Patient Satisfaction Rate PubMed · 2013
    93. The Prostamide-Related Glaucoma Therapy, Bimatoprost, Offers a Novel Approach for Treating Scalp Alopecias The FASEB Journal · 2012
    94. A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2011
    95. Innovative Use of Spironolactone as an Antiandrogen in the Treatment of Female Pattern Hair Loss PubMed · 2010
    96. Permeation of Topically Applied Caffeine Through Human Skin – A Comparison of In Vivo and In Vitro Data BJCP. British journal of clinical pharmacology/British journal of clinical pharmacology · 2009
    97. Effect of Caffeine and Testosterone on the Proliferation of Human Hair Follicles In Vitro International Journal of Dermatology · 2007
    98. Effects of Minoxidil 2% vs. Cyproterone Acetate Treatment on Female Androgenetic Alopecia: A Controlled, 12-Month Randomized Trial British Journal of Dermatology · 2002